Dr Reddys Laboratories (RDY) Prepaid Assets (2009 - 2026)
Dr Reddys Laboratories (RDY) posted Prepaid Assets of $384.1 million for Q2 2026, down 3.15% on a QoQ basis from $396.6 million in Q1 2026, and up 3.48% year-over-year from $371.2 million in Q2 2025.
Analysis
Dr Reddys Laboratories (RDY) Prepaid Assets (2009 - 2026) Analysis & Trends
Dr Reddys Laboratories has reported Prepaid Assets for 18 years, with the latest figure at $384.1 million in Q2 2026.
- On a quarterly basis, Prepaid Assets rose 3.48% year-over-year to $384.1 million in Q2 2026; TTM through Jun 2026 was $384.1 million, a 3.48% increase from a year earlier, with the FY2026 full-year figure at $386.0 million, up 9.35% from the prior year.
- Prepaid Assets was $384.1 million for Q2 2026 at Dr Reddys Laboratories, down from $396.6 million in the prior quarter.
- The five-year high for Prepaid Assets was $413.1 million in Q3 2025, with the low at $184.9 million in Q1 2022.
- Average Prepaid Assets over 5 years is $300.1 million, with a median of $287.9 million recorded in 2024.
- The sharpest annual moves came in 2022 and 2023: Prepaid Assets retreated 7.09% in 2022, then soared 32.05% in 2023.
- Over 5 years, Prepaid Assets stood at $233.1 million in 2022, then gained by 21.11% to $282.4 million in 2023, then rose by 20.59% to $340.5 million in 2024, then advanced by 7.13% to $364.8 million in 2025, then grew by 5.29% to $384.1 million in 2026.
- The last three Prepaid Assets figures came in at $384.1 million (Q2 2026), $396.6 million (Q1 2026), and $364.8 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.63 Bn | 38.97 Bn | 2.15 Bn |
| 2 | Viatris | 19.19 Bn | 18.30 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.36 Bn | 520.30 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 995.52 Mn | 705.40 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 404.35 Mn | 363.10 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 384.10 Mn |
| Mar 31, 2026 | 396.61 Mn |
| Dec 31, 2025 | 364.80 Mn |
| Sep 30, 2025 | 413.10 Mn |
| Jun 30, 2025 | 371.20 Mn |
| Mar 31, 2025 | 348.08 Mn |
| Dec 31, 2024 | 340.51 Mn |
| Sep 30, 2024 | 336.89 Mn |
| Jun 30, 2024 | 293.50 Mn |
| Mar 31, 2024 | 271.66 Mn |
| Dec 31, 2023 | 282.38 Mn |
| Sep 30, 2023 | 271.25 Mn |
| Jun 30, 2023 | 225.32 Mn |
| Mar 31, 2023 | 244.14 Mn |
| Dec 31, 2022 | 233.15 Mn |
| Sep 30, 2022 | 229.90 Mn |
| Jun 30, 2022 | 210.17 Mn |
| Mar 31, 2022 | 184.88 Mn |
| Dec 31, 2021 | 186.79 Mn |
| Sep 30, 2021 | 214.56 Mn |